Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly Non Operating Income of $165000.0 for Q1 2026, down 84.06% year-on-year from $1.0 million in Q1 2025, and down 65.19% on a QoQ basis from $474000.0 in Q4 2025.
Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Non Operating Income for 5 consecutive years, with $165000.0 the latest figure, recorded in Q1 2026.
- Quarterly Non Operating Income fell 84.06% year-over-year to $165000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (down 637.02% YoY) and the FY2025 annual result came in at -$23.1 million, down 298.9% from the prior year.
- Non Operating Income declined to $165000.0 in Q1 2026 per IXHL's latest filing, from $474000.0 in the prior quarter.
- Over the last five years, Non Operating Income for IXHL reached as high as $4.2 million in Q3 2023 and fell as low as -$24.1 million in Q2 2025.
- A 5-year average of -$688857.1 and a median of $597500.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 16465.0% — and 2025, when it slumped 826.68%.
- Year by year, Non Operating Income stood at $721000.0 in 2022, then soared by 280.31% to $2.7 million in 2023, then slumped by 132.46% to -$890000.0 in 2024, then surged by 153.26% to $474000.0 in 2025, then slumped by 65.19% to $165000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $165000.0, $474000.0, and $387000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 165,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | -24.08 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | -890,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 721,000.00 |